These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
823 related articles for article (PubMed ID: 33135795)
1. Characterization of antibody responses to SARS-CoV-2 in convalescent COVID-19 patients. Liu C; Yu X; Gao C; Zhang L; Zhai H; Hu Y; Liu E; Wang Q; Gao Y; Wei D; Zhang D; Han Y; Zhang X J Med Virol; 2021 Apr; 93(4):2227-2233. PubMed ID: 33135795 [TBL] [Abstract][Full Text] [Related]
2. Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients. Zhu L; Xu X; Zhu B; Guo X; Xu K; Song C; Fu J; Yu H; Kong X; Peng J; Huang H; Zou X; Ding Y; Bao C; Zhu F; Hu Z; Wu M; Shen H Microbiol Spectr; 2021 Oct; 9(2):e0059021. PubMed ID: 34550000 [TBL] [Abstract][Full Text] [Related]
3. Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel. Mboumba Bouassa RS; Péré H; Tonen-Wolyec S; Longo JD; Moussa S; Mbopi-Keou FX; Mossoro-Kpinde CD; Grésenguet G; Veyer D; Bélec L J Med Virol; 2021 Apr; 93(4):2196-2203. PubMed ID: 33107601 [TBL] [Abstract][Full Text] [Related]
4. Clinical diagnostic performance evaluation of five immunoassays for antibodies to SARS-CoV-2 diagnosis in a real-life routine care setting. Akyala AI; Awayimbo JR; Ogo AC; Chima NJ; Billyrose OMA; Engom AOG Pan Afr Med J; 2021; 39():3. PubMed ID: 34178231 [TBL] [Abstract][Full Text] [Related]
5. Over 1-year duration and age difference of SARS-CoV-2 antibodies in convalescent COVID-19 patients. Zeng F; Wu M; Wang J; Li J; Hu G; Wang L J Med Virol; 2021 Dec; 93(12):6506-6511. PubMed ID: 34170519 [TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2-Specific Antibody and T Cell Response Kinetics According to Symptom Severity. Kim JY; Kwon JS; Bae S; Cha HH; Lim JS; Kim MC; Chung JW; Park SY; Lee MJ; Kim BN; Jung J; Kim MJ; Shin EC; Kim SH Am J Trop Med Hyg; 2021 Jun; 105(2):395-400. PubMed ID: 34143752 [TBL] [Abstract][Full Text] [Related]
7. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak. Shu H; Wang S; Ruan S; Wang Y; Zhang J; Yuan Y; Liu H; Wu Y; Li R; Pan S; Ouyang Y; Yuan S; Zhou P; Shang Y Virol Sin; 2020 Dec; 35(6):744-751. PubMed ID: 32720214 [TBL] [Abstract][Full Text] [Related]
8. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19. Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects. Achiron A; Gurevich M; Falb R; Dreyer-Alster S; Sonis P; Mandel M Clin Microbiol Infect; 2021 Sep; 27(9):1349.e1-1349.e6. PubMed ID: 33975009 [TBL] [Abstract][Full Text] [Related]
10. Profile of Immunoglobulin G and IgM Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Qu J; Wu C; Li X; Zhang G; Jiang Z; Li X; Zhu Q; Liu L Clin Infect Dis; 2020 Nov; 71(16):2255-2258. PubMed ID: 32337590 [TBL] [Abstract][Full Text] [Related]
11. Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan. Yokoyama R; Kurano M; Morita Y; Shimura T; Nakano Y; Qian C; Xia F; He F; Kishi Y; Okada J; Yoshikawa N; Nagura Y; Okazaki H; Moriya K; Seto Y; Kodama T; Yatomi Y PLoS One; 2021; 16(3):e0247711. PubMed ID: 33661990 [TBL] [Abstract][Full Text] [Related]
12. Highlighted Prospects of an IgM/IgG Antibodies Test in Identifying Individuals With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. Li Y; He Q; Yu R; Jiang H; Wang W; Feng D; Hou G; Zhou H; Jiang Y; Xiang Z Arch Pathol Lab Med; 2021 Jan; 145(1):39-45. PubMed ID: 32966561 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the correlation between the access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization test. Kitagawa Y; Imai K; Matsuoka M; Fukada A; Kubota K; Sato M; Takada T; Noguchi S; Tarumoto N; Maesaki S; Takeuchi S; Maeda T J Med Virol; 2022 Jan; 94(1):335-341. PubMed ID: 34524695 [TBL] [Abstract][Full Text] [Related]
14. Clinical validation of a second generation anti-SARS-CoV-2 IgG and IgM automated chemiluminescent immunoassay. Pieri M; Nuccetelli M; Nicolai E; Sarubbi S; Grelli S; Bernardini S J Med Virol; 2021 Apr; 93(4):2523-2528. PubMed ID: 33463719 [TBL] [Abstract][Full Text] [Related]
15. Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort. Zhang S; Xu K; Li C; Zhou L; Kong X; Peng J; Zhu F; Bao C; Jin H; Gao Q; Zhao X; Zhu L Front Immunol; 2022; 13():829665. PubMed ID: 35154152 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of the serum IgM and IgG to SARS-CoV-2 in coronavirus disease-2019. Wu LX; Wang H; Gou D; Fu G; Wang J; Guo BQ J Clin Lab Anal; 2021 Jan; 35(1):e23649. PubMed ID: 33184940 [TBL] [Abstract][Full Text] [Related]
17. Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2. Wu JL; Tseng WP; Lin CH; Lee TF; Chung MY; Huang CH; Chen SY; Hsueh PR; Chen SC J Infect; 2020 Sep; 81(3):435-442. PubMed ID: 32553841 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 IgM and IgG antibodies in human plasma. Bundschuh C; Egger M; Wiesinger K; Gabriel C; Clodi M; Mueller T; Dieplinger B Clin Chim Acta; 2020 Oct; 509():79-82. PubMed ID: 32526218 [TBL] [Abstract][Full Text] [Related]
19. Antibody kinetics and serologic profiles of SARS-CoV-2 infection using two serologic assays. Kweon OJ; Lim YK; Kim HR; Kim MC; Choi SH; Chung JW; Lee MK PLoS One; 2020; 15(10):e0240395. PubMed ID: 33091042 [TBL] [Abstract][Full Text] [Related]
20. Multicenter evaluation of four immunoassays for the performance of early diagnosis of COVID-19 and assessment of antibody responses of patients with pneumonia in Taiwan. Lin YC; Lee YL; Cheng CY; Tseng WP; Wu JL; Lin CH; Chung MY; Kang CM; Lee YF; Chen CP; Huang CH; Liu CE; Cheng SH; Chen SC; Chen SY; Hsueh PR J Microbiol Immunol Infect; 2021 Oct; 54(5):816-829. PubMed ID: 33676864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]